1. Home
  2. ALT vs CVGW Comparison

ALT vs CVGW Comparison

Compare ALT & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • CVGW
  • Stock Information
  • Founded
  • ALT 1997
  • CVGW 1924
  • Country
  • ALT United States
  • CVGW United States
  • Employees
  • ALT N/A
  • CVGW N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • CVGW Specialty Foods
  • Sector
  • ALT Health Care
  • CVGW Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • CVGW Nasdaq
  • Market Cap
  • ALT 457.0M
  • CVGW 517.5M
  • IPO Year
  • ALT N/A
  • CVGW N/A
  • Fundamental
  • Price
  • ALT $8.68
  • CVGW $27.17
  • Analyst Decision
  • ALT Buy
  • CVGW Hold
  • Analyst Count
  • ALT 7
  • CVGW 1
  • Target Price
  • ALT $20.00
  • CVGW $32.00
  • AVG Volume (30 Days)
  • ALT 4.3M
  • CVGW 115.5K
  • Earning Date
  • ALT 11-12-2024
  • CVGW 01-14-2025
  • Dividend Yield
  • ALT N/A
  • CVGW 1.84%
  • EPS Growth
  • ALT N/A
  • CVGW N/A
  • EPS
  • ALT N/A
  • CVGW N/A
  • Revenue
  • ALT $52,000.00
  • CVGW $1,011,635,000.00
  • Revenue This Year
  • ALT N/A
  • CVGW N/A
  • Revenue Next Year
  • ALT N/A
  • CVGW $3.27
  • P/E Ratio
  • ALT N/A
  • CVGW N/A
  • Revenue Growth
  • ALT N/A
  • CVGW 45.46
  • 52 Week Low
  • ALT $2.50
  • CVGW $20.30
  • 52 Week High
  • ALT $14.84
  • CVGW $31.26
  • Technical
  • Relative Strength Index (RSI)
  • ALT 60.55
  • CVGW 45.37
  • Support Level
  • ALT $6.95
  • CVGW $26.61
  • Resistance Level
  • ALT $9.06
  • CVGW $30.02
  • Average True Range (ATR)
  • ALT 0.94
  • CVGW 0.78
  • MACD
  • ALT 0.05
  • CVGW -0.10
  • Stochastic Oscillator
  • ALT 45.13
  • CVGW 16.42

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.

Share on Social Networks: